Godavari Drugs Limited (BOM:530317)
133.40
+3.60 (2.77%)
At close: Oct 16, 2026
Godavari Drugs Revenue
Godavari Drugs had revenue of 281.08M INR in the quarter ending June 30, 2026, with 17.99% growth. This brings the company's revenue in the last twelve months to 1.11B, up 5.44% year-over-year. In the fiscal year ending March 31, 2026, Godavari Drugs had annual revenue of 1.06B, down -6.65%. That makes Godavari Drugs the 36,594th largest company in the world by revenue and 3,090th in India.
Revenue (ttm)
1.11B
Revenue Growth
+5.44%
P/S Ratio
1.22
Revenue / Employee
9.90M
Employees
112
Market Cap
1.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.06B | -75.42M | -6.65% |
| Mar 31, 2025 | 1.13B | -438.72M | -27.90% |
| Mar 31, 2024 | 1.57B | -24.03M | -1.51% |
| Mar 31, 2023 | 1.60B | -16.37M | -1.01% |
| Mar 31, 2022 | 1.61B | 384.48M | 31.31% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bal Pharma | 3.34B |
| Parnax Lab | 2.52B |
| Medico Remedies | 2.38B |
| Lactose (India) | 1.71B |
| Aayush Wellness | 1.66B |
| Makers Laboratories | 1.49B |
| Kerala Ayurveda | 1.36B |
| Oxygenta Pharmaceutical | 1.35B |